Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Angioneurotic edema.

L M Prisant1

  • 1Section of Cardiology, Hypertension Unit, Medical College of Georgia, Augusta, GA 30912-3105, USA.

Journal of Clinical Hypertension (Greenwich, Conn.)
|August 11, 2001
PubMed
Summary
This summary is machine-generated.

Angioneurotic edema, a swelling of the face and airways, can be caused by certain blood pressure medications. Most cases occur within six months of starting therapy, and prompt airway management is crucial.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mortality in patients with microvascular disease.

Journal of clinical hypertension (Greenwich, Conn.)·2004
Same author

Coarctation of the aorta: a secondary cause of hypertension.

Journal of clinical hypertension (Greenwich, Conn.)·2004
Same author

Arterial elasticity among normotensive subjects and treated and untreated hypertensive subjects.

Blood pressure monitoring·2002
Same author

Verapamil revisited: a transition in novel drug delivery systems and outcomes.

Heart disease (Hagerstown, Md.)·2002
Same author

Hypertension images: electrocardiographic left ventricular hypertrophy.

Journal of clinical hypertension (Greenwich, Conn.)·2001
Same author

Hypertension and chronotherapy: shifting the treatment paradigm.

American journal of hypertension·2001

Area of Science:

  • Cardiology
  • Pharmacology
  • Immunology

Background:

  • Angioneurotic edema presents as nonpitting edema affecting facial areas and the airway.
  • It is associated with medications like angiotensin-converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs).

Purpose of the Study:

  • To summarize the causes, risk factors, and management of angioneurotic edema.
  • To highlight the association between ACE inhibitors and angioneurotic edema.

Main Methods:

  • Literature review and synthesis of existing data on angioneurotic edema.
  • Analysis of medication-induced angioedema cases.

Main Results:

  • Angioneurotic edema frequently occurs with ACE inhibitors, less so with ARBs.

Related Experiment Videos

  • The majority of episodes manifest within the initial six months of treatment.
  • Risk factors include prior idiopathic angioedema, African American ethnicity, and post-transplant immunosuppression.

    • Conclusions:

    • Treatment focuses on preventing airway compromise.
    • Understanding predisposing factors aids in risk assessment and patient monitoring.